123 related articles for article (PubMed ID: 38349474)
1. Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning.
Kang Z; Zhao YX; Qiu RSQ; Chen DN; Zheng QS; Xue XY; Xu N; Wei Y
Cancer Immunol Immunother; 2024 Feb; 73(3):41. PubMed ID: 38349474
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of macrophage-related genes in prostate cancer by integrated analysis of single-cell and bulk RNA sequencing.
Zhang J; Li Z; Chen Z; Shi W; Xu Y; Huang Z; Lin Z; Dou R; Lin S; Jiang X; Li M; Jiang S
Aging (Albany NY); 2024 Apr; 16(8):6809-6838. PubMed ID: 38663915
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of single-cell and bulk RNA sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness.
Li X; Zheng C; Xue X; Wu J; Li F; Song D; Li X
Funct Integr Genomics; 2023 Apr; 23(2):115. PubMed ID: 37010617
[TBL] [Abstract][Full Text] [Related]
5. Integration of single-cell and bulk RNA sequencing to establish a prognostic signature based on tumor-associated macrophages in colorectal cancer.
Li H; Pan L; Guo J; Lao J; Wei M; Huang F
BMC Gastroenterol; 2023 Nov; 23(1):385. PubMed ID: 37950156
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a disulfidptosis and M2 TAM-related classifier for bladder cancer to explore tumor subtypes, immune landscape and drug treatment.
Ren C; Wang Q; Xu Z; Pan Y; Li Y; Liu X
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15805-15818. PubMed ID: 37668798
[TBL] [Abstract][Full Text] [Related]
7. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.
Zhu W; Wu J; Huang J; Xiao D; Li F; Wu C; Li X; Zeng H; Zheng J; Lai W; Wen X
Front Immunol; 2023; 14():1122670. PubMed ID: 37122696
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
Front Immunol; 2022; 13():914577. PubMed ID: 35757739
[TBL] [Abstract][Full Text] [Related]
10. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
Liu W; Wang M; Wang M; Liu M
Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
[TBL] [Abstract][Full Text] [Related]
11. Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.
Zhu W; Zeng H; Huang J; Wu J; Wang Y; Wang Z; Wang H; Luo Y; Lai W
J Transl Med; 2023 Nov; 21(1):782. PubMed ID: 37925432
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer.
Guan H; Peng R; Fang F; Mao L; Chen Z; Yang S; Dai C; Wu H; Wang C; Feng N; Xu B; Chen M
J Cell Physiol; 2020 Dec; 235(12):9729-9742. PubMed ID: 32406953
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment.
Hu B; Zhang X; Zhu S; Wang C; Deng Z; Wang T; Wu Y
Eur J Med Res; 2024 Jan; 29(1):92. PubMed ID: 38297388
[TBL] [Abstract][Full Text] [Related]
14. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.
Lissbrant IF; Stattin P; Wikstrom P; Damber JE; Egevad L; Bergh A
Int J Oncol; 2000 Sep; 17(3):445-51. PubMed ID: 10938382
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tumor-associated macrophages in prostate cancer transgenic mouse models.
de Groot AE; Myers KV; Krueger TEG; Kiemen AL; Nagy NH; Brame A; Torres VE; Zhang Z; Trabzonlu L; Brennen WN; Wirtz D; De Marzo AM; Amend SR; Pienta KJ
Prostate; 2021 Jul; 81(10):629-647. PubMed ID: 33949714
[TBL] [Abstract][Full Text] [Related]
16. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
Front Immunol; 2022; 13():994019. PubMed ID: 36177006
[TBL] [Abstract][Full Text] [Related]
17. Identification of a six-gene prognostic signature for bladder cancer associated macrophage.
Jiang Y; Qu X; Zhang M; Zhang L; Yang T; Ma M; Jing M; Zhang N; Song R; Zhang Y; Yang Z; Zhang Y; Pu Y; Fan J
Front Immunol; 2022; 13():930352. PubMed ID: 36275756
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer-specific dysregulated genes with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation.
Liu C; Zhang Y; Li X; Wang D
Ann N Y Acad Sci; 2022 Jun; 1512(1):154-173. PubMed ID: 35247207
[TBL] [Abstract][Full Text] [Related]
19. ALOX5 acts as a key role in regulating the immune microenvironment in intrahepatic cholangiocarcinoma, recruiting tumor-associated macrophages through PI3K pathway.
Chen J; Tang Y; Qin D; Yu X; Tong H; Tang C; Tang Z
J Transl Med; 2023 Dec; 21(1):923. PubMed ID: 38124204
[TBL] [Abstract][Full Text] [Related]
20. A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data.
Huang J; Liu D; Li J; Xu J; Dong S; Zhang H
Ann Med; 2023; 55(2):2260387. PubMed ID: 37729607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
